Use of eculizumab in patients with allogeneic stem cell transplant-associated thrombotic microangiopathy: A study from the SFGM-TC

Thrombotic microangiopathy (TMA) occurring after allogeneic hematopoietic stem cell transplantation (HSCT) has a devastating prognosis. Response rates to current therapies (mainly plasma exchange) are unsatisfactory. Thrombotic microangiopathy after allogeneic HSCT shares similarities with atypical...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Transplantation 2015-09, Vol.99 (9), p.1953-1959, Article 1953
Hauptverfasser:	de Fontbrune, Flore Sicre, Galambrun, Claire, Sirvent, Anne, Huynh, Anne, Faguer, Stanislas, Nguyen, Stephanie, Bay, Jacques-Olivier, Neven, Bénédicte, Moussi, Julie, Simon, Laurence, Xhaard, Alienor, Resche-Riggon, Matthieu, O'Meara, Alix, Fremeaux-Bacchi, Veronique, Veyradier, Agnes, Socié, Gérard, Coppo, Paul, de Latour, Régis Peffaut
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Antibodies, Monoclonal, Humanized - therapeutic use Child Child, Preschool Female France Graft vs Host Disease - etiology Graft vs Host Disease - mortality Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - mortality Humans Male Middle Aged Retrospective Studies Risk Factors Severity of Illness Index Survival Analysis Thrombotic Microangiopathies - diagnosis Thrombotic Microangiopathies - drug therapy Thrombotic Microangiopathies - etiology Thrombotic Microangiopathies - mortality Time Factors Transplantation, Homologous Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!